Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan A Fleming

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|February 14, 2022
Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq PlatformUlrike Gerdemann, Ryan A Fleming, James Kaminski, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
PTPN2-KO CAR-T Cells Demonstrate Enhanced Effector Function, CNS Infiltration, and Toxicity in a Non-Human Primate CAR-T ModelFrancesca Alvarez Calderon, Ryan A Fleming, Marlana Winschel, et al.
Blood|April 1, 2024
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primatesJames Kaminski, Ryan A Fleming, Francesca Alvarez-Calderon, et al.
Blood|June 12, 2025
A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHDUlrike Gerdemann, Kyle Kimler, Matthew R Warren, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|February 14, 2022
Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq PlatformUlrike Gerdemann, Ryan A Fleming, James Kaminski, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
PTPN2-KO CAR-T Cells Demonstrate Enhanced Effector Function, CNS Infiltration, and Toxicity in a Non-Human Primate CAR-T ModelFrancesca Alvarez Calderon, Ryan A Fleming, Marlana Winschel, et al.
Blood|April 1, 2024
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primatesJames Kaminski, Ryan A Fleming, Francesca Alvarez-Calderon, et al.
Blood|June 12, 2025
A single dose of a CD137 antibody-drug conjugate protects nonhuman primate allogeneic HCT recipients against acute GVHDUlrike Gerdemann, Kyle Kimler, Matthew R Warren, et al.
Pageof 1